Cisplatin-induced nephrotoxicity and targets of nephroprotection: an update

• Published in: Archives of toxicology Vol. 86; no. 8; pp. 1233 - 1250
• Main Authors: dos Santos, Neife Aparecida Guinaim, Carvalho Rodrigues, Maria Augusta, Martins, Nadia Maria, dos Santos, Antonio Cardozo
• Format: Journal Article
• Language: English
• Published: Berlin/Heidelberg Springer-Verlag 01.08.2012; Springer Nature B.V
• Subjects: Animals; Antineoplastic Agents - toxicity; Biomedical and Life Sciences; Biomedicine; Cancer therapies; Cell Death - drug effects; Cisplatin - toxicity; Cytoprotection; Drug dosages; Environmental Health; Humans; Kidney - drug effects; Kidney - metabolism; Kidney - pathology; Kidney Diseases - chemically induced; Kidney Diseases - metabolism; Kidney Diseases - pathology; Kidney Diseases - prevention & control; Kidneys; Occupational Medicine/Industrial Medicine; Oxidative stress; Pharmacology/Toxicology; Protective Agents - therapeutic use; Review Article; Signal Transduction - drug effects; Testicular cancer; Toxicity; Oxidative stress; Mitochondria; Molecular mechanisms; Nephroprotection; Nephrotoxicity; Cisplatin; Apoptosis

Cisplatin is a highly effective antitumor agent whose clinical application is limited by the inherent nephrotoxicity. The current measures of nephroprotection used in patients receiving cisplatin are not satisfactory, and studies have focused on the investigation of new possible protective strategie...